NHS National Generics Pharmaceuticals - Supply Chain Resilience

Buyer: NHS England

Deadline

Not available — this notice may describe a possible future opportunity.

Region

Not specified

Value

£35,010,320

Type

Award,contract

SME fit

—

Duration

—

Description

NHS National Generics Pharmaceuticals - Supply Chain Resilience Period of framework agreement: Dates detailed below, with an option or options to extend (at the discretion of the Authority) for a period or periods up to a total of 48 months. Periods of call-offs under the framework agreement: CM/PHG/25/5739/01 – Orals (plus non-parenteral) Products CESW: (Midlands and Southwest): 1st September 2026 to 31st May 2028 (21 months) NWLN: (Northwest and London North): 1st September 2026 to 31st May 2028 (21 months) LSNE: (London South and Northeast): 1st September 2026 to 31st May 2028 (21 months) CM/PHG/25/5739/02 – Hospital Only Products DLS (London South) & DNE (North-East): 1st September 2026 to 31st May 2028 (21 months) DLN (London North) & DNW (North-West): 1st September 2026 to 31st May 2028 (21 months) DCE (Central/Midlands) & DSW (South-West): 1st September 2026 to 30th September 2027 (13 months) This tender is for lines that have recently been terminated or unable to be awarded on previous tenders. Please note we have previously referred to these as “Housekeeping” tenders.

Awarded to

Amarox Limited £35,010,320 Aspire Pharma Limited £35,010,320 MILPHARM LIMITED £35,010,320 Teva UK Limited £35,010,320 Wockhardt UK Limited £35,010,320 Colonis Pharma Ltd £4,213,176 Crescent Pharma Limited £4,213,176 Day Lewis Medical Ltd £4,213,176 Ennogen Healthcare International Limited £4,213,176 G.L. Pharma UK Limited £4,213,176 Morningside Pharmaceuticals Ltd £4,213,176 Northumbria Pharma Limited £4,213,176 SELECTIVE SUPPLIES LIMITED £4,213,176 CIPLA (EU) LIMITED £35,010,320 Baxter Healthcare Ltd £35,010,320 Brown & Burk UK Ltd £35,010,320 Jannsen-Cilag Limited £35,010,320 Ascend Laboratories £35,010,320 Hikma Pharmaceuticals International Ltd £35,010,320 MACARTHYS LABORATORIES LIMITED £35,010,320 SUN PHARMA UK LIMITED £35,010,320 Viatris UK Healthcare Limited £35,010,320 ZENTIVA PHARMA UK LIMITED £35,010,320 Fresenius Kabi Limited £35,010,320 Glenmark Pharmaceuticals Europe Ltd £35,010,320 ACCORD-UK LTD £35,010,320

Quick actions

View original notice

Key details

CPV category: —
Procurement method: Open procedure
Published: 01 May 2026 14:38
VCSE suitable: —

Reference

OCID: ocds-h6vhtk-060abf
Notice ID: CM/PHG/25/5739
In our database since: 17 Aug 2026